Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 39 Ovarian Neoplasms 32 Triple Negative Breast Neoplasms 19 Prostatic Neoplasms 17 Fallopian Tube Neoplasms 16 Neoplasm Metastasis 14 Pancreatic Neoplasms 9 Neoplasms 9 Endometrial Neoplasms 9 Carcinoma, Non-Small-Cell Lung 7 Small Cell Lung Carcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Glioma 6 Stomach Neoplasms 5 Sarcoma 5 Lung Neoplasms 5 Glioblastoma 5 Squamous Cell Carcinoma of Head and Neck 4 Metastatic Castration-resistant Prostate Cancer 4 Carcinoma, Ovarian Epithelial 4 Solid Tumors 3 Recurrence 3 Osteosarcoma 3 Neuroendocrine Tumors 3 Lymphoma, Non-Hodgkin 3 Cholangiocarcinoma 3 Urinary Bladder Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Prostatic Neoplasms, Castration-Resistant 2

Interventions

pembrolizumab 14 Nivolumab 11 Ipilimumab 10 cabozantinib 6 Axitinib 6 belzutifan 5 Radiosurgery 5 atezolizumab 4 Sunitinib 4 palbociclib 3 lenvatinib 3 Surveys and Questionnaires 3 Radiotherapy 3 Pluvicto 3 Everolimus 3 Blood Specimen Collection 3 Biopsy 3 zimberelimab 2 pazopanib 2 cemiplimab 2 Therapeutics 2 Methods 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 trebananib 1 toripalimab 1 tocilizumab 1 temsirolimus 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × olaparib × 1 year × Clear all

NCT03786796 2026-03-30

ORCHID

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡